IIIM1
IIIM1 is an orally active anti-inflammatory peptide. IIIM1 ameliorates the symptoms of experimental autoimmune encephalomyelitis (EAE) by stimulating the proliferation of regulatory T cells and inducing them to produce RA1, and regulating the cytokine balance. IIIM1 can be used in the research of multiple sclerosis (MS) [1].
Product Specifications
CAS Number
500217-51-6
UNSPSC
12352209
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
O=C(NCC(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)N
Molecular Formula
C44H69N15O13
Molecular Weight
1016.11
References & Citations
[1]Shapira E, et al. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells. J Autoimmun. 2010 Aug;35 (1) :98-106.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
IL-2; IL-6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IGPCHTLGZT3 1 Each
Innovative Grade US Origin Porcine Heart and Lungs With Trachea/Esophagus/Epiglottis Frozen
Sign In for Pricing
View Details 